News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer
Paolo Tarantino/X
Feb 14, 2025, 09:48

Paolo Tarantino: No statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a paper Tom Powles and his colleagues authored on X:

“TROPiCS-04 trial out on Annals of Oncology: no statistical improvement in OS with the Trop2 ADC SG vs TPC in met urothelial cancer, with higher rate of G5 AEs with SG. Led to the withdrawal of SG approval for mUC. No association between Trop2 exp and SG activity.”

Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial

Authors: Thomas Powles et al.

Paolo Tarantino

A. Necchi C. Vulsteke C.N. Sternberg C.S. Sima cancer F. Boateng I. Durán J. Bellmunt J. Guo J. Waldes L. Wang M. De Santis M. Gross-Goupil M. Kovalenko M. Sierecki OncoDaily Oncology P. Grivas P.J. Goebell Paolo Tarantino R. Morales-Barrera S. Tagawa S.H. Park T. Powles Y. Loriot
Special Coverage
Blog
Jun 27, 2025, 06:22
Join the International Lung Cancer Survivorship Conference on Sep 26 and 27 - LUNGevity Foundation
Blog
Jun 27, 2025, 06:17
IARC and American Cancer Society Launch The Cancer Atlas, Fourth Edition
Blog
Jun 27, 2025, 06:06
Douglas Flora: Through The Looking Glass - Sharpening Oncology's Vision
Blog
Jun 27, 2025, 05:56
Dinesh Pendharkar: Roz Nayi Jeet It's a Reflection of What We Witness Every Day
Blog
Jun 27, 2025, 05:53
ESMO - Early Registration is Open for the Molecular Analysis for Precision Oncology Congress 2025
Dialogues
Jun 27, 2025, 05:47
Top Biotechs at ASCO: Marwan Fakih on a Novel CTLA-4 Approach in MSS Colorectal Cancer
Career
Jun 27, 2025, 05:43
Kerry Burnstein Was Awarded J. Enloe Dodson Chair in Cancer Research - Sylvester Comprehensive Cancer Center
Blog
Jun 27, 2025, 05:35
The Message from ASCO 2025 Is Clear: Oncology Is Evolving Fast - NCODA
Dialogues
Jun 27, 2025, 05:35
Top Biotechs at ASCO: Kohkan Shamsi on How RadMD Delivers Imaging for Cancer Drug Development
Blog
Jun 27, 2025, 05:26
Lucas de Toca: Eliminating Cervical Cancer Can Be a Reality
Dialogues
Jun 27, 2025, 05:23
Top Biotechs at ASCO: Ying Huang on Carvykti’s 5-Year Data and Expanding CAR-T Therapy in Myeloma
Blog
Jun 27, 2025, 05:19
Hilary Robbins Presented at the G7 Cancer Conference on Poor Prognosis Cancers - IARC